Sylvie Hermouet, Mathias Vilaine. The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?. Haematologica 2011;96(11):1575-1579; https://doi.org/10.3324/haematol.2011.055392.